Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-12-22

FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for PrezcoBix (darunavir ethanolate and cobicistat) from Janssen Products, LP. This action updates the labeling to refle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

SUPPL AP for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT)